Neutralizing antibodies hamper IFNbeta bioactivity and treatment effect on MRI in patients with MS.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 17101906.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We measured neutralizing antibodies (NABs) and the in vivo biologic response to interferon-beta on neopterin and beta(2)-microglobulin blood levels. All NAB-negative patients had an in vivo biologic response (full or partial), whereas all high-level positive patients had no response. High-level NAB patients had more MRI activity than NAB-negative patients (p = 0.031). Patients with a full response had less MRI activity than patients without biologic response (p = 0.032).
Medical subject headings
- Antibodies
- Drug Resistance
- Interferon-beta
- Multiple Sclerosis